Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure

Results of a pilot study investigating CAR T therapy combined with Ibrutinib in chronic lymphocytic leukemia after relapsed from Ibrutinib. Abstract only